-3.8 | | Thap11 | 'metaphase II oocyte' vs 'germinal vesicle oocyte' | cell type | Transcription profiling of mouse in vivo matured MII oocytes and fully in vivo grown germinal vesicle oocytes to identify gene transcripts linked to epigenetic reprogramming |
-2.1 | | Thap11 | 'adult definitive erythroid cell' vs 'primitive erythroid cell' in 'reticulocyte' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
-1.9 | | Thap11 | 'cycloheximide and 100 unit per milliliter interferon gamma' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
-1.9 | | Thap11 | 'subventicular zone of the lateral ventricle' vs 'cerebellum' | organism part | Expression data from adult Shh-responding astroglia cells in mice |
-1.7 | | Thap11 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'Hoxb8-FL; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
-1.7 | | Thap11 | 'Yersinia pestis' vs 'control' in 'neutrophil' | cell type, infect, sampling site | Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague |
1.5 | | Thap11 | 'TUT4 deficiency; TUT7 knockout' vs 'wild type' | phenotype | Microarray profiling of mouse pachytene cells deficient for UPF2 or both TUT4 and TUT7 |
1.5 | | Thap11 | 'chemical hypoxia' vs 'control' | growth condition | Comparison of gene expression in whole blood of mice subjected to chemical hypoxia in vivo. |
-1.4 | | Thap11 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'bone marrow macrophage from 129P2 mouse strain' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
-1.4 | | Thap11 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'derived macrophage from E14 Traf2 mutant cell line' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
-1.4 | | Thap11 | 'cycloheximide and 100 unit per milliliter interferon alpha' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
-1.4 | | Thap11 | 'cycloheximide' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
-1.4 | | Thap11 | 'hippocampus' vs 'cerebellum' | organism part | Expression data from adult Shh-responding astroglia cells in mice |
1.3 | | Thap11 | 'induced extraembryonic endoderm stem cell; grown in XEN cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
-1.3 | | Thap11 | 'Kit ligand' vs 'none' in 'wasp knockout' | compound, genotype | Transcription profiling of bone marrow–derived mast cells from WASP-deficient mice after stimulation with kit ligand |
-1.3 | | Thap11 | 'lipopolysaccharide; 1 microgram per milliliter' vs 'none' in 'Nfkbiz-/-' | compound, genotype | Inhibitor of NFκB ζ (IκBζ) is a transcriptional key regulator of monocyte chemoattractant protein-1 (MCP-1/CCL2) |
1.3 | | Thap11 | 'induction of polymicrobial sepsis' vs 'control' at '24 hour' in '1.5 to 3 month mice' | age, time, treatment | Aged Mice are Unable to Mount an Effective Myeloid Response to Sepsis |
-1.2 | | Thap11 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'derived macrophage from E14 cell line' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
-1.2 | | Thap11 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'primary cell line; MEF2C/D knockout' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
-1.2 | | Thap11 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'Hoxb8-FL; MEF2A knockout' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
1.2 | | Thap11 | 'butyrate' vs 'none' | compound | HDAC inhibition by TSA and Butyrate In Flt3L-elicited DC |
1.2 | | Thap11 | 'TUT4; TUT7 double knockout' vs 'wild type' | phenotype | Microarray profiling of mouse pachytene cells deficient for UPF2 or both TUT4 and TUT7 |
-1.2 | | Thap11 | 'polarized with E coli lipopolysacharide and INF-gamma' vs 'untreated' | compound, treatment | Expression data from polarized macrophages: effect of p53 |
1.2 | | Thap11 | 'E2f8 knock-out' vs 'wild type' | genotype | Expression data from WT, E2f8 KO, Rb KO and Rb;E2f8 DKO spleen Ter19+CD71high sorted cells |
1.2 | | Thap11 | 'Rb;E2f8 knock-out' vs 'wild type' | genotype | Expression data from WT, E2f8 KO, Rb KO and Rb;E2f8 DKO spleen Ter19+CD71high sorted cells |
-1.1 | | Thap11 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
1.1 | | Thap11 | 'extraembryonic endoderm stem cell; grown in XEN cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
-1.1 | | Thap11 | 'neurosphere in differentiation medium; 12 day' vs 'neurosphere; 0 day' in 'Cstb knockout' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
1.1 | | Thap11 | 'trichostatin A' vs 'none' | compound | HDAC inhibition by TSA and Butyrate In Flt3L-elicited DC |
-1.1 | | Thap11 | 'Porphyromonas gingivalis; normal' vs 'normal' | infect, phenotype | hyperlipidemia impaired innate response |
-1.1 | | Thap11 | 'lipopolysaccharide; 10 nanogram per milliliter and prostaglandin E2; 1 micromolar and interferon beta; 100 units per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
-1 | | Thap11 | 'Kit ligand' vs 'none' in 'wild type' | compound, genotype | Transcription profiling of bone marrow–derived mast cells from WASP-deficient mice after stimulation with kit ligand |
1 | | Thap11 | 'dibenzazapine 10 micromoles per kilogram' vs 'none' | compound, dose | Transcription profiling by array of pancreatic cells from C57BL/6 mice following dibenzazepine treatment |
-1 | | Thap11 | 'control mice [Gp130f/f]; cecal ligation and puncture' vs 'control mice [Gp130f/f]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
1 | | Thap11 | 'myeloid lineage restricted progenitor cell' vs 'long term hematopoietic stem cell' in 'Elp3fl/fl' | cell type, genotype | RNA-seq of long-term hematopoietic stem cells and myeloid progenitors of control mice or mice conditionally deficient for Trp53 or Elp3 or both genes in the hematopoietic system |
1 | | Thap11 | 'Stella maternal / zygotic knockout' vs 'wild type genotype' in '1-cell embryo' | developmental stage, genotype | Transcription profiling of wild type and Stella knockout oocytes, wild type and Stella maternal/zygotic knockout embryos to study to the role of Stella in early mouse development |
1 | | Thap11 | 'tristetrapolin knockout' vs 'wild type' in 'actinomycin D' at '120 minute' | compound, genotype, time | Transcription profiling by array of fibroblasts from TTP knock out mice |
-1 | | Thap11 | 'megakaryocyte' vs 'hematopoietic stem cell' | cell type | Transcription profiling by array of primary megakaryocytes (MEG) and erythroblasts (ERY) developed from murine fetal liver hematopoietic stem cells |
-1 | | Thap11 | 'recombinant human interleukin-2; 100 unit per milliliter; 2 hour' vs 'control; 0 hour' | compound, time | Transcription profiling by array of mouse CTLL-2 cell line treated with recombinant human interleukin-2 |